Health
Johnson & Johnson vaccine: Why it’s worth the minuscule risk – Inverse
The benefits for the one-dose Covid-19 vaccine outweigh the risks.
The CDC and the FDA lifted the pause
on the Johnson & Johnson Covid-19 vaccine on April 23, 2021, but the labels and fact sheets given to patients will carry a warning about the exceedingly low risk of developing blood clots.
Also, close monitoring of the J&J vaccine along with the Moderna and Pfizer vaccines that were given emergency use authorization will continue.
Dr. William Petri, an infectious disease physician and immunologist at the University of Virginia School of Medicine, explains…
-
General23 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
General9 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News24 hours agoWorker rushed to hospital after becoming trapped in machinery during horror workplace accident in Salisbury
-
General21 hours agoThe Church of England’s ‘turning point’ to irrelevancy